1Department of pharmaceutical chemistry,Sahyadri college of pharmacy,Methwade,Sangola
2Associate Professor of Sahyadri College of Pharmacy, Methwade ,Sangola
The UV method for the estimation of Metoprolol and Azelnidipine in bulk and pharmaceutical dosage Form was developed. The identification and quantification was carried out by using UV-VIS spectrophotometer. 0.1% Perchloric acid and Acetonitrile [50:50] used as Diluent for sample and standard preparation and also as a Blank. The wavelength of drug Metoprolol and Azelnidipine were found to be 224 nm and 260 nm respectively.LOD,LOQ values obtained from regression equations of metoprolol and azelnidipine were 1.23,3.72,0.31 and 0.94?g/ml. ?curacy was obtained as 99.94 and 99.85 for Metoprolol and Azelnidipine respectively. %Recovery was obtained as 99.101 and 99.101 respectively. % RSD of the metoprolol and azelnidipine were and found to be 0.26 and 0.57 respectively. attempt has been made to develop UV and Reverse Phase High Performance Liquid Chromatographic method for the estimation of Metoprolol and Azelnidipine in bulk and pharmaceutical dosage form and to validate the developed method according to ICH Q2 (R1) guidelines.Analytical method development was started with the preliminary studies of the drug Metoprolol and Azelnidipine
Azelnidipine is a calcium channel blocker that belongs to the dihydropyridine class. Japan's Daiichi-Sankyo Pharmaceuticals, Inc. is the company responsible for marketing it. When compared to other calcium channel blockers, it has a delayed onset of action and generates a long-lasting drop in blood pressure. Patients who have hypertension can have a progressive reduction in their blood pressure when they take azelnidipine, which is a vasodilator. Because of its vasodilatory effects, azelnidipine does not cause reflex tachycardia, in contrast to other drugs that belong to the same medication class. Metoprolol is a cardioselective beta-1-adrenergic receptor inhibitor that inhibits beta1 receptors in a competitive manner while having limited or no effects on beta-2 receptors when administered orally to humans in dosages of less than 100 mg. Through its negative inotropic and chronotropic actions, it brings to a reduction in cardiac output.
MATERIAL AND METHODS:
1. Method Parameters:
a. Diluent: 0.1% Perchloric acid : Acetonitrile (50: 50%, v/v)
Preparation of 0.1% Perchloric acid:
Add 0.1 ml of Perchloric acid in 100 ml of Water, Mix and filtered.
b. Wavelength: ?1 = 224 nm; ?2 = 260 nm
2. Standard Preparation:
a. Metoprolol Standard Stock Solution-I (MSSS-I):
i. Initially Prepare a Standard Stock Solution (MSSS-I) of by adding 25 mg of Metoprolol in 10 ml volumetric flask & add 5 ml diluent, mix for 2 minutes and make the volume to 10 ml with diluent. (Conc. of Metoprolol = 2500 µg/ml).
b. Azelnidipine Standard Stock Solution-II (ASSS-II):
i. Then prepare a Standard Stock Solution (ASSS-II) of Azelnidipine by adding 8 mg in 10 ml volumetric flask & add 5 ml diluent, mix for 2 minutes and make the volume to 10 ml with diluent. (Conc. of Azelnidipine = 800 µg/ml).
c. Then add 0.1 ml of MSSS-I &0.1 ml ASSS-I in 10 ml volumetric flask and add 5 ml diluent and vortex and make up the volume with diluent. (Conc. of Metoprolol= 25 µg/ml &Azelnidipine = 8 µg/ml).
3. Selection of Wavelength:
25µg/ml of MET Working Standard and 8µg/ml of AZD Working Standardwere scanned in the UV range of 190-400 nm. The overlay of both the spectrum was recorded. From the overlain spectra wavelengths 224 nm (?max of MET) and 260 nm (?max of AZD) were selected for analysis of both drugs using simultaneous method. (?1-224 nm and ?2-260 nm).
The absorbance at ?1 and ?2 was measured and the concentration was calculated using following formula;
Where,
Cx and Cy are the concentrations of Metoprolol and Azelnidipine, respectively,
A1 and A2 are the absorbances of sample at ?1 and ?2, respectively,
ax1 and ax2 are the absorptivity of Metoprolol at ?1 and ?2, respectively,
ay1 and ay2 are the absorptivity of Azelnidipine at ?1 and ?2, respectively.
UV Method Validation
a. Linearity:
b. LOD/ LOQ:
Can be calculated by using AVONA Technique.
c. Repeatability :
A single sample was prepared as described and 6 injections were made from same sample; checked for RSD.
d. Accuracy:
d. Intra- & Inter-day Precision:
RESULT :-
UV method
Selection of Wavelength
The Standard and Sample solution was scanned from 190 to 400 nm by using UV-VIS spectrophotometer against Diluent (0.1% Perchloric acid: Acetonitrile (50:50)) as blank and the maximum absorption of standard and sample solution were recorded.
Result:
The UV scans for both the drugs is given below:
Figure 1: UV Scan of Metoprolol
Figure 2: UV Scan of Azelnidipine
UV Method Validation of Metoprolol and Azelnidipine
It was confirmed with blank and working standard run that there was zero absorbance of blank at set lambda in UV Spectrophotometer.
The peak response is directly proportional to the concentration of drug and was found to be linear in the range of 8-12µg/ml.
The linearity data for Metoprolol and Azelnidipine is give below:
Table 2: Linearity data for Metoprolol
Figure 3: Linearity graph of Metoprolol
Table 3: Linearity data for Azelnidipine
Figure 4: Linearity graph of Azelnidipine
From the above data it was found that the correlation coefficient was found to be 0.999 for both the drugs i.e. Metoprolol and Azelnidipine respectively, which was found to be within the acceptance criteria of 0.998.
C. LOD and LOQ
Based on the linearity data, LOD and LOQ was calculated and reported as below:
Table 4: LOD & LOQ of Metoprolol
Table 5: LOD & LOQ of Azelnidipine
From the above data it was found that:
d. Repeatability
Repeatability was performed for both the APIs, the recorded absorbance is shown below:
Table 6: Repeatability of Metoprolol and Azelnidipine
From the above data, it can be seen that the %RSD for 6 replicate injections of Metoprolol and Azelnidipine are 0.39% and 0.71% respectively. The percentage RSD (<2>
e. Accuracy
The accuracy was performed at 3 different levels i.e. 80%, 100% and 120%. The accuracy data for Metoprolol and Azelnidipine is given below:
Table 7: Accuracy of Metoprolol
Table 8: Accuracy of Azelnidipine
f. Intra & Inter day Precision
The Standard solution of Metoprolol and Azelnidipine were examine for Intra and Inter day Precision, the data is shown below:
Table 9: Intra & Inter day Precision of Metoprolol and Azelnidipine
The data of the Assay of Metoprolol and Azelnidipine is given below:
Table 10: Assay of Metoprolol and Azelnidipin
CONCLUSION
The UV method developed for the estimation of Metoprolol and Azelnidipine was validated as per the ICH guidelines. Validation data demonstrates that, these methods are accurate, precise, simple, and economic and can be used in the routine analysis of Metoprolol and Azelnidipine in various formulations.
REFERENCE
15. Lange R, Balny C. UV-visible derivative spectroscopy under high pressure. Biochim Biophys Acta BBA - Protein Struct Mol Enzymol. 2002;1595(1-2):80-93.
Yogita M. Mane ,Kale S. Sagar , Development And Validation Of UV Method For Simultaneous Estimation Of Metoprolol Succinate And Azelnidipine In Pharmaceutical Dosage Form, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 7, 292-300. https://doi.org/10.5281/zenodo.12658344